Abstracts Archive - Page 1899 of 2425 - ACR Meeting Abstracts

Abstract Number: 2299 • 2014 ACR/ARHP Annual Meeting
M-Ficolin and Masp-2 As Inflammatory Markers in Oligoarticular and Systemic Juvenile Idiopathic Arthritis
Christine Petri¹, Steffen Thiel², Jens Christian Jensenius² and Troels Herlin¹, ¹Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark, ²Biomedicine, Aarhus University, Aarhus, Denmark
Background/Purpose The lectin pathway of the complement plays a crucial role in the pathogenesis of various inflammatory processes. The lectin pathway proteins are activated through…
Abstract Number: 2300 • 2014 ACR/ARHP Annual Meeting
Biologic Treatment in Systemic Juvenile Idiopathic Arthritis: Single Center Experience
Buthaina Al adba¹, Rayfel Schneider² and Earl Silverman³, ¹paediatric rheumatology, sickkids hospital, Toronto, ON, Canada, ²Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ³Division of Rheumatology, Hosp for Sick Children, Toronto, ON, Canada
Background/Purpose: The prevalence of juvenile idiopathic arthritis (JIA) is approximately 3.3/1000 children and 10- 15% have the systemic form (SJIA). Biologics, specifically anti-IL -1 and…
Abstract Number: 2301 • 2014 ACR/ARHP Annual Meeting
The New Proposal Classification Criteria for Juvenile Spondyloarthropaties
Ozgur Kasapcopur¹, Metin Sezen¹, Kenan Barut¹ and Cengizhan Acikel², ¹Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey, ²Department of Bioistatistics, Gulhane Military Medical Academy, Ankara, Turkey
Background/Purpose Juvenile spondyloarthropathies (JSpA) are a group of rheumatologic diseases with a disease onset before 16 years of age and are characterized with enthesitis, lower…
Abstract Number: 2302 • 2014 ACR/ARHP Annual Meeting
Classification of Juvenile Spondyloarthropathies According to ASAS Criteria
Marìa M. Katsicas¹ and Ricardo A. G. Russo², ¹Immunology & Rheumatology., Hospital de Pediatrìa Garrahan, Buenos Aires, Argentina, ²Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina
Background/Purpose The juvenile spondyloarthropathies (JSpA) are a group of related seronegative rheumatic diseases characterized by involvement of the axial , peripheral large joints and entheses.…
Abstract Number: 2303 • 2014 ACR/ARHP Annual Meeting
Clinical Observation on Ankylosing Spondylitis Patients with Different Phenotypes
Zhiming Lin¹, Jun Qi², Jieruo Gu³ and Pingping Zhang⁴, ¹The Affiliated Third Hospital of Sun Yat-san University, Rheumatology, Guangzhou, China, ²The Third Affiliated Hospital of Sun Yat-sen University, guangzhou, China, ³Rheumatology, The Affiliated Third Hospital of Sun Yat-san University, Rheumatology, Guangzhou, China, ⁴Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Background/Purpose :Juvenile and adult forms of ankylosing spondylitis (AS) have been shown different in initial symptoms,clinical presentation ,imaging manifestations and prognosis.So,according to the diagnostic criteria…
Abstract Number: 2304 • 2014 ACR/ARHP Annual Meeting
Positive HLA-B27 in Juvenile Spondyloarthritis Is Associated to Early Sacroiliitis and Progression to Ankylosing Spondylitis
Mariana O Perez¹, Nadia E Aikawa¹, Solange Carrasco¹, Percival D Sampaio-Barros², Celio R. Gonçalves², Carla G.S. Saad², Julio C. B. Moraes² and Cláudia Goldeinstein-Schainberg², ¹University of São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Juvenile spondyloarthritis (JSpA) manifests with axial and peripheral involvement, enthesitis and HLAB27+ in 60-90% children. Radiological sacroiliitis may occur within 10 years, representing an…
Abstract Number: 2305 • 2014 ACR/ARHP Annual Meeting
Improving Screening for Hyperlipidemia in Patients with Rheumatoid Arthritis at an Academic Rheumatology Practice
Ashwini Komarla¹ and Alexis Ogdie², ¹Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA
Background/Purpose Cardiovascular disease is the leading cause of mortality in the rheumatoid arthritis (RA) population. However, cardiovascular risk factors such as hyperlipidemia are undertreated in…
Abstract Number: 2306 • 2014 ACR/ARHP Annual Meeting
Quality of Care for Cardiovascular Prevention in RA: Compliance with Diabetes Screening Guidelines
Timothy J Schmidt^1,2, J Antonio Avina-Zubieta^2,3,4, Eric C. Sayre³, Michal Abrahamowicz⁵, John M. Esdaile^2,6,7 and Diane Lacaille^8,9,10, ¹Arthritis Research Centre of Canada, Richmind, BC, Canada, ²Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁵Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁶Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁷Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁸Arthritis Research Centre of Canada, Vancouver, BC, Canada, ⁹Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁰University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada
Background/Purpose: Comorbidities are increasingly recognized as significant contributors of decreased quality of life, and increased mortality in RA. RA is associated with an increased risk…
Abstract Number: 2307 • 2014 ACR/ARHP Annual Meeting
Cardiovascular Disease Prevention in Rheumatologic Disease: Assessing Screening in a Primary Care Setting
Micaela Bayard¹ and Magdalena Cadet², ¹Rheumatology, New York Hospital of Queens/ Weill Cornell Medical Center, New York, NY, ²Rheumatology and Immunology, Duke University School of Medicine, Durham, NC
Background/Purpose: To determine the proportion of patients diagnosed with rheumatologic disease receiving preventive health care according to US Preventive Services Task Force recommendations with emphasis…
Abstract Number: 2308 • 2014 ACR/ARHP Annual Meeting
Quality of Care for Cardiovascular Disease Prevention in RA: Compliance Lipid Screening Guidelines
Timothy J Schmidt^1,2, J Antonio Avina-Zubieta^3,4,5, Eric C. Sayre⁴, Michal Abrahamowicz⁶, John M. Esdaile^3,7,8 and Diane Lacaille^9,10,11, ¹Arthritis Research Centre of Canada, Richmind, BC, Canada, ²Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Richmond, BC, Canada, ³Experimental Medicine, University of British Columbia, Department of Experimental Medicine, Vancouver, BC, Canada, ⁴Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁵Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁶Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, ⁷Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁸Rheumatology, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁹Medicine, University of British Columbia, Vancouver, BC, Canada, ¹⁰Arthritis Research Centre of Canada, Vancouver, BC, Canada, ¹¹University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada
Background/Purpose: Comorbidities are increasingly recognized as significant contributors of reduced quality of life and increased mortality in RA. Cardiovascular diseases are the leading cause of…
Abstract Number: 2309 • 2014 ACR/ARHP Annual Meeting
A Novel Approach to Assess Wait-Times to Rheumatologists
Jessica Widdifield¹, Claire Bombardier², J. Carter Thorne³, R. Liisa Jaakkimainen⁴, J. Michael Paterson¹, Sasha Bernatsky⁵, Jacqueline Young¹, Laura Wing¹, Noah Ivers⁶, Debra Butt¹, Vivian Poon¹, Vandana Ahluwalia⁷ and Karen Tu¹, ¹Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto, ON, Canada, ³Southlake Regional Health Centre, Newmarket, Newmarket, ON, Canada, ⁴Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁵Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁶University of Toronto, Toronto, ON, Canada, ⁷William Osler Health Center, Brampton, ON, Canada
Background/Purpose: Previous studies quantifying delays in assessment of patients by rheumatologists have studied patients from rheumatology clinics and thus include all patients who ultimately had…
Abstract Number: 2310 • 2014 ACR/ARHP Annual Meeting
Improving Access to Health Care in Rheumatology Practices through Initiation of an Outpatient Urgent Care Clinic, a Paradigm Shift
Ruchi Jain, Meenakshi Jolly, Theodore Pincus, Isabel Castrejón, Annie Huang and Joel A. Block, Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: Urgent care clinics are built into some primary care practices, but no reports are available of urgent care clinics in rheumatology settings. Many rheumatologists…
Abstract Number: 2311 • 2014 ACR/ARHP Annual Meeting
Tele-Rheumatology: Despite Improved Access Could There be a Potential Delay in Care without a Skilled “Presenter”?
Zsolt Kulcsar¹, Daniel A. Albert², Krista Merrihew³ and John Mecchella⁴, ¹Rheumatology/Leadership Preventive Medicine Residency, Dartmouth Hitchcock Medical Center, lebanon, NH, ²Rheumatology, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, ³Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, ⁴Rheumatology, Giesel school of medicine and Dartmouth Hitchcock Medical Center, Lebanon, NH
Background/Purpose: Arthritis treatment in New Hampshire (NH) is complicated by the fact that a large proportion of the population lives in rural areas (60%) with…
Abstract Number: 2272 • 2014 ACR/ARHP Annual Meeting
Assessment of Transition Readiness in Adolescents and Young Adults with Rheumatic and Other Chronic Health Conditions
Gabrielle Paul¹, Stephanie LaCount², Charles H. Spencer³, Gloria C. Higgins⁴, Karla Jones⁵, Brendan Boyle⁶, Manmohan K. Kamboj⁷, Christopher Smallwood⁸ and Stacy P. Ardoin⁹, ¹College of Medicine, Ohio State University, Columbus, OH, ²Pediatrics, Ohio State University, Columbus, OH, ³Rheumatology, Nationwide Childrens Hospital, Columbus, OH, ⁴Pediatric Rheumatology Ohio State University, Nationwide Childrens Hosp, Columbus, OH, ⁵Pediatrics, Nationwide Children's Hospital, Ohio, OH, ⁶Gastroenterology, Nationwide Children's Hospital, Columbus, OH, ⁷Endocrinology, Nationwide Children's Hospital, Columbus, OH, ⁸Family Medicine, Ohio State Univeristy, Columbus, OH, ⁹Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH
Background/Purpose The transition from pediatric to adult care is a vulnerable period. The lack of objective measures of transition readiness is a barrier to improving…
Abstract Number: 2273 • 2014 ACR/ARHP Annual Meeting
Does a Standardized Multidisciplinary Approach Improve Outcomes for Children with NMDA Receptor Antibody Encephalitis? : A Preliminary Assessment of a Single Center Experience
Mered Parnes¹, Amber Stocco², Trung Nguyen³, Jun Teruya⁴, Jeanine Graf³ and Eyal Muscal⁵, ¹Child Neurology, Baylor College of Medicine, Houston, TX, ²Integris Pediatric Neurology, Oklahoma City, OK, ³Pediatrics-critical care, Baylor College of Medicine, Houston, TX, ⁴Pathology, Baylor College of Medicine, Houston, TX, ⁵Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Houston, TX
Background/Purpose: NMDA receptor antibody encephalitis (NMDAR) is a potentially devastating isolated autoimmune condition affecting children and young adults that was mostly unrecognized prior to 2007.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].